Evidence map›Paper›PMID 24294352›Full record

ArticleInternational journal of clinical and experimental pathology2013

Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma.

Xiang Yuan, Jiangtu He, Fenyong Sun, Jiang Gu

Abstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Jmjd2c maintains the ALDHCancer biology & therapy · 2024
    Article
  2. Review
  3. Article
  4. CXCL5/NF-Journal of oncology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. miR-143 inhibits migration and invasion through regulating LASP1 in human esophageal cancer.International journal of clinical and experimental pathology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiang YuanDepartment of Pathology, School of Basic Medical Science, Peking University Beijing 100083, China.
Jiangtu He
Fenyong Sun
Jiang Gu
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testis specific 10 (TSGA10) was originally identified as a testis-specific protein and tumor-associated antigen in a number of cancer types. In this study, we found that down-regulation of TSGA10 was associated with increased malignancy and clinical features of esophageal squamous cell carcinomas (ESCCs). Moreover, increased expression of TSGA10 inhibited, while its knockdown promoted, tumor formation in vivo in nude mice. At the 3'UTR of the TSGA10 gene we identified two binding sites for microRNA-577 (miR-577). Further investigation demonstrated that expression levels of miR-577 and TSGA10 were negatively correlated to each other in ESCC cell lines and tumor samples. Moreover, manipulation of miR-577 and TSGA10 expression confirmed that miR-577 can regulate TSGA10 and in turn affect cell proliferation in vitro. Additionally, with flow cytometry and manipulation of the mir-577/TSGA10 axis, it was found that mir-577/TSGA10 axis influenced the growth of ESCC through regulating the G1-S phase transition. We also obtained evidence to establish that mir-577/TSGA10 axis activation was always accompanied by inactivation of the p53 pathway or the Rb pathway or both, thus, the latter two pathways are obligatory for progression of ESCCs with mir-577/TSGA10 axis activation. In addition, we found that such an interactive pathway in regulating cancer cell proliferation was restricted to a few cancer types including ESCC, but not uniformly applicable to other cancer types. This newly discovered regulatory mechanism provides a new dimension for ESCC diagnosis and therapy.

Indexed as

3' Untranslated RegionsAnimalsBinding SitesCarcinoma, Squamous CellCell Line, TumorCell ProliferationCytoskeletal ProteinsEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaFemaleG1 Phase Cell Cycle CheckpointsGene Expression Regulation, NeoplasticHumansMaleMiceMice, Nude3' Untranslated RegionsCytoskeletal ProteinsMicroRNAsMIRN577 microRNA, humanProteinsRetinoblastoma ProteinTP53 protein, humanTSGA10 protein, humanTumor Suppressor Protein p53ESCCG1-S phase transitionmiR-577p53/p21 pathwayRb/p16 pathwayTSGA10

Identifiers

PMID24294352
PMCPMC3843246
OpenAlexW179313026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.